BACTIGUARD HLDG B
Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management … Read more
Market Cap & Net Worth: BACTIGUARD HLDG B (5JE)
BACTIGUARD HLDG B (F:5JE) has a market capitalization of $42.70 Million (€41.60 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #25675 globally and #2809 in its home market, demonstrating a 1.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BACTIGUARD HLDG B's stock price €1.34 by its total outstanding shares 31043885 (31.04 Million).
BACTIGUARD HLDG B Market Cap History: 2020 to 2026
BACTIGUARD HLDG B's market capitalization history from 2020 to 2026. Data shows change from $427.00 Million to $42.70 Million (-37.14% CAGR).
BACTIGUARD HLDG B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BACTIGUARD HLDG B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5JE by Market Capitalization
Companies near BACTIGUARD HLDG B in the global market cap rankings as of March 19, 2026.
Key companies related to BACTIGUARD HLDG B by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
BACTIGUARD HLDG B Historical Marketcap From 2020 to 2026
Between 2020 and today, BACTIGUARD HLDG B's market cap moved from $427.00 Million to $ 42.70 Million, with a yearly change of -37.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €42.70 Million | -17.54% |
| 2025 | €51.78 Million | -48.41% |
| 2024 | €100.38 Million | -40.34% |
| 2023 | €168.25 Million | -45.34% |
| 2022 | €307.82 Million | -39.09% |
| 2021 | €505.39 Million | +18.36% |
| 2020 | €427.00 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BACTIGUARD HLDG B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.70 Million USD |
| MoneyControl | $42.70 Million USD |
| MarketWatch | $42.70 Million USD |
| marketcap.company | $42.70 Million USD |
| Reuters | $42.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.